The store will not work correctly when cookies are disabled.
5-tert-butyl-6-chloro-N-(3-chloro-5-hydroxyphenyl)-2-pyrazinecarboxamide
ID: ALA2288606
Cas Number: 448191-21-7
PubChem CID: 76309308
Max Phase: Preclinical
Molecular Formula: C15H15Cl2N3O2
Molecular Weight: 340.21
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)c1ncc(C(=O)Nc2cc(O)cc(Cl)c2)nc1Cl
Standard InChI: InChI=1S/C15H15Cl2N3O2/c1-15(2,3)12-13(17)20-11(7-18-12)14(22)19-9-4-8(16)5-10(21)6-9/h4-7,21H,1-3H3,(H,19,22)
Standard InChI Key: WSFHIVWNYVXBOT-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
16.2435 -25.2735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8308 -25.9853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8308 -24.5617 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0094 -25.9853 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6008 -25.2735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0094 -24.5617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0648 -25.2735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4734 -25.9853 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.4734 -24.5617 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.2947 -24.5617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7074 -23.8498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5288 -23.8498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9373 -24.5617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5288 -25.2735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7074 -25.2735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9373 -25.9853 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.9373 -23.1380 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
14.6008 -23.8498 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
13.7795 -25.2735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3668 -25.9853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9582 -25.2735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3668 -24.5617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 2 0
2 4 2 0
4 5 1 0
5 6 2 0
3 6 1 0
7 8 2 0
7 9 1 0
1 7 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
10 15 2 0
14 16 1 0
12 17 1 0
9 10 1 0
6 18 1 0
19 20 1 0
19 22 1 0
19 21 1 0
5 19 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 340.21 | Molecular Weight (Monoisotopic): 339.0541 | AlogP: 4.04 | #Rotatable Bonds: 2 |
Polar Surface Area: 75.11 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.49 | CX Basic pKa: ┄ | CX LogP: 4.07 | CX LogD: 4.04 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.87 | Np Likeness Score: -1.27 |
References
1. Opletalová V, Hartl J, Patel A, Palát K, Buchta V.. (2002) Ring substituted 3-phenyl-1-(2-pyrazinyl)-2-propen-1-ones as potential photosynthesis-inhibiting, antifungal and antimycobacterial agents., 57 (2): [PMID:11902656] [10.1016/s0014-827x(01)01187-9] |